NYSE:CRL
Charles River Laboratories International, Inc.
- Stock
Last Close
194.19
22/11 21:00
Market Cap
10.44B
Beta: 1.34
Volume Today
575.72K
Avg: 590.58K
PE Ratio
23.49
PFCF: 30.28
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 89.22M - | 91.39M 2.43% | 94.78M 3.71% | 105.39M 11.19% | 121.42M 15.21% | 144.28M 18.82% | 173.18M 20.03% | 192.42M 11.11% | 227.48M 18.22% | 318.03M 39.81% | |
average payables | 32.79M - | 35.24M 7.48% | 52.58M 49.18% | 73.16M 39.14% | 72.04M 1.53% | 88.87M 23.36% | 116.99M 31.63% | 160.30M 37.03% | 202.02M 26.03% | 187.43M 7.23% | |
average receivables | 239.31M - | 264.03M 10.33% | 317.06M 20.08% | 397.03M 25.22% | 451.13M 13.63% | 493.14M 9.31% | 565.89M 14.75% | 630.31M 11.38% | 697.64M 10.68% | 766.38M 9.85% | |
book value per share | 14.42 - | 15.77 9.36% | 17.80 12.89% | 22.01 23.67% | 27.47 24.83% | 33.54 22.09% | 42.68 27.23% | 50.40 18.10% | 58.57 16.22% | 69.91 19.35% | |
capex per share | -1.22 - | -1.36 11.43% | -1.18 13.55% | -1.74 47.63% | -2.92 68.25% | -2.88 1.28% | -3.36 16.57% | -4.55 35.32% | -6.39 40.50% | -6.19 3.13% | |
capex to depreciation | -0.59 - | -0.67 12.95% | -0.44 34.52% | -0.63 43.98% | -0.87 37.75% | -0.71 18.06% | -0.71 0.05% | -0.86 21.51% | -1.07 24.04% | -1.01 5.11% | |
capex to operating cash flow | -0.23 - | -0.22 2.59% | -0.19 16.10% | -0.26 40.63% | -0.32 21.81% | -0.29 7.97% | -0.30 4.30% | -0.30 1.32% | -0.52 74.28% | -0.47 11.13% | |
capex to revenue | -0.04 - | -0.05 5.76% | -0.03 29.13% | -0.04 34.95% | -0.06 39.28% | -0.05 13.26% | -0.06 6.26% | -0.06 13.44% | -0.08 26.38% | -0.08 5.55% | |
cash per share | 3.78 - | 2.98 21.19% | 2.58 13.29% | 4.05 56.83% | 4.09 1.11% | 4.90 19.76% | 4.63 5.57% | 4.82 4.03% | 4.60 4.44% | 5.38 16.85% | |
days of inventory on hand | 39.39 - | 41.11 4.36% | 33.80 17.77% | 36.32 7.44% | 32.73 9.87% | 35.26 7.73% | 36.63 3.87% | 32.96 10.02% | 37.15 12.72% | 52.84 42.23% | |
days payables outstanding | 14.96 - | 16.09 7.52% | 24.16 50.18% | 24.59 1.80% | 16.96 31.05% | 24.47 44.32% | 24.16 1.28% | 32.79 35.72% | 29.90 8.80% | 23.47 21.50% | |
days sales outstanding | 72.57 - | 72.31 0.36% | 79.03 9.30% | 84.49 6.92% | 76.06 9.98% | 71.58 5.90% | 77.11 7.73% | 66.28 14.05% | 69.07 4.20% | 68.98 0.13% | |
debt to assets | 0.41 - | 0.42 1.12% | 0.46 9.15% | 0.39 14.18% | 0.43 10.68% | 0.43 1.26% | 0.39 8.95% | 0.42 6.87% | 0.41 1.98% | 0.43 5.06% | |
debt to equity | 1.16 - | 1.18 1.74% | 1.48 25.37% | 1.10 25.76% | 1.27 15.56% | 1.23 3.15% | 1.01 17.65% | 1.15 14.05% | 1.04 9.64% | 0.98 6.29% | |
dividend yield | 0.00 - | ||||||||||
earnings yield | 0.04 - | 0.04 5.12% | 0.04 7.74% | 0.02 45.06% | 0.04 78.04% | 0.03 19.45% | 0.03 14.19% | 0.02 27.91% | 0.04 108.56% | 0.04 11.14% | |
enterprise value | 3.62B - | 4.47B 23.59% | 4.70B 5.17% | 6.18B 31.47% | 6.83B 10.54% | 9.17B 34.28% | 14.38B 56.81% | 21.25B 47.76% | 13.94B 34.41% | 14.95B 7.30% | |
enterprise value over ebitda | 17.76 - | 19.37 9.10% | 16.08 17.01% | 16.78 4.40% | 16.65 0.83% | 16.29 2.16% | 18.71 14.89% | 25.91 38.45% | 14.13 45.45% | 14.49 2.52% | |
ev to operating cash flow | 14.40 - | 15.60 8.35% | 15.75 0.95% | 19.53 24.01% | 15.48 20.75% | 19.07 23.17% | 26.31 37.98% | 27.93 6.15% | 22.49 19.47% | 21.86 2.78% | |
ev to sales | 2.79 - | 3.28 17.64% | 2.79 14.73% | 3.33 19.00% | 3.01 9.39% | 3.50 16.08% | 4.92 40.57% | 6.00 22.04% | 3.50 41.60% | 3.62 3.32% | |
free cash flow per share | 4.16 - | 4.80 15.25% | 5.17 7.73% | 4.92 4.73% | 6.28 27.51% | 6.99 11.25% | 7.67 9.78% | 10.58 37.93% | 5.80 45.14% | 7.10 22.35% | |
free cash flow yield | 0.06 - | 0.06 7.47% | 0.07 13.23% | 0.04 33.68% | 0.06 24.92% | 0.05 18.20% | 0.03 33.74% | 0.03 5.96% | 0.03 7.04% | 0.03 12.78% | |
graham net net | -16.44 - | -19.68 19.69% | -30.11 53.00% | -27.25 9.52% | -39.69 45.68% | -47.64 20.02% | -51.70 8.51% | -71.75 38.78% | -71.90 0.21% | -67.71 5.82% | |
graham number | 29.69 - | 33.75 13.69% | 36.31 7.57% | 35.87 1.21% | 54.02 50.61% | 62.48 15.64% | 84.02 34.49% | 93.89 11.75% | 112.30 19.60% | 120.46 7.26% | |
income quality | 1.93 - | 1.88 2.53% | 1.91 1.47% | 2.52 31.76% | 1.94 22.91% | 1.89 2.50% | 1.50 20.96% | 1.91 27.49% | 1.26 34.06% | 1.42 13.18% | |
intangibles to total assets | 0.27 - | 0.35 31.18% | 0.44 25.28% | 0.40 8.02% | 0.48 20.19% | 0.48 1.39% | 0.47 0.48% | 0.54 13.58% | 0.50 6.82% | 0.48 3.47% | |
interest coverage | 14.87 - | 13.70 7.87% | 8.57 37.45% | 9.66 12.68% | 5.20 46.18% | 5.77 11.00% | 5.01 13.20% | 7.98 59.41% | 10.98 37.57% | 4.52 58.88% | |
interest debt per share | 16.94 - | 18.89 11.49% | 26.86 42.22% | 24.74 7.87% | 36.12 45.97% | 42.38 17.34% | 44.84 5.80% | 59.52 32.73% | 62.12 4.38% | 70.83 14.01% | |
inventory turnover | 9.27 - | 8.88 4.18% | 10.80 21.62% | 10.05 6.93% | 11.15 10.95% | 10.35 7.17% | 9.96 3.73% | 11.07 11.14% | 9.83 11.28% | 6.91 29.69% | |
invested capital | 1.16 - | 1.18 1.74% | 1.48 25.37% | 1.10 25.76% | 1.27 15.56% | 1.23 3.15% | 1.01 17.65% | 1.15 14.05% | 1.04 9.64% | 0.98 6.29% | |
market cap | 3.00B - | 3.72B 24.21% | 3.58B 3.80% | 5.20B 45.08% | 5.36B 3.08% | 7.40B 38.21% | 12.47B 68.46% | 18.57B 48.88% | 11.07B 40.37% | 12.16B 9.85% | |
net current asset value | -573.95M - | -743.70M 29.58% | -1.20B 61.51% | -1.04B 13.48% | -1.62B 55.85% | -2.00B 23.78% | -2.15B 7.03% | -3.16B 47.16% | -3.14B 0.57% | -2.93B 6.78% | |
net debt to ebitda | 3.03 - | 3.23 6.45% | 3.82 18.34% | 2.67 30.26% | 3.59 34.63% | 3.14 12.59% | 2.48 20.90% | 3.27 31.59% | 2.90 11.08% | 2.70 6.92% | |
net income per share | 2.72 - | 3.21 18.18% | 3.29 2.51% | 2.60 21.08% | 4.72 81.73% | 5.17 9.54% | 7.35 42.16% | 7.77 5.74% | 9.57 23.09% | 9.22 3.60% | |
operating cash flow per share | 5.38 - | 6.16 14.39% | 6.35 3.03% | 6.66 4.97% | 9.20 38.13% | 9.87 7.27% | 11.03 11.77% | 15.13 37.14% | 12.19 19.39% | 13.29 9.00% | |
payables turnover | 24.40 - | 22.69 6.99% | 15.11 33.41% | 14.84 1.77% | 21.52 45.03% | 14.91 30.71% | 15.11 1.30% | 11.13 26.32% | 12.21 9.65% | 15.55 27.39% | |
receivables turnover | 5.03 - | 5.05 0.36% | 4.62 8.50% | 4.32 6.47% | 4.80 11.08% | 5.10 6.27% | 4.73 7.18% | 5.51 16.34% | 5.28 4.03% | 5.29 0.13% | |
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.09 - | 0.11 21.03% | 0.10 8.61% | 0.07 30.53% | 0.11 61.23% | 0.10 9.69% | 0.13 23.01% | 0.12 4.47% | 0.13 6.47% | 0.11 12.49% | |
revenue per share | 27.83 - | 29.32 5.35% | 35.76 21.98% | 39.12 9.39% | 47.26 20.80% | 53.79 13.81% | 59.01 9.70% | 70.39 19.29% | 78.25 11.17% | 80.26 2.57% | |
roe | 0.19 - | 0.20 8.06% | 0.18 9.19% | 0.12 36.18% | 0.17 45.59% | 0.15 10.28% | 0.17 11.74% | 0.15 10.47% | 0.16 5.91% | 0.13 19.23% | |
roic | 0.09 - | 0.10 12.26% | 0.08 20.26% | 0.06 30.81% | 0.09 61.29% | 0.08 12.75% | 0.08 2.72% | 0.09 6.85% | 0.08 7.13% | 0.07 14.87% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 14.42 - | 15.77 9.36% | 17.80 12.89% | 22.01 23.67% | 27.47 24.83% | 33.54 22.09% | 42.68 27.23% | 50.40 18.10% | 58.57 16.22% | 69.91 19.35% | |
stock based compensation to revenue | 0.02 - | 0.03 23.06% | 0.03 11.81% | 0.02 8.73% | 0.02 11.80% | 0.02 4.57% | 0.02 11.81% | 0.02 4.78% | 0.02 8.29% | 0.02 5.77% | |
tangible asset value | 204.39M - | 45.93M 77.53% | -328.18M 814.51% | -110.65M 66.28% | -519.72M 369.69% | -563.50M 8.42% | -453.10M 19.59% | -1.18B 160.67% | -781.67M 33.82% | -300.10M 61.61% | |
tangible book value per share | 4.38 - | 0.99 77.46% | -6.98 806.64% | -2.33 66.61% | -10.84 365.12% | -11.56 6.68% | -9.14 20.92% | -23.48 156.82% | -15.38 34.49% | -5.83 62.09% | |
working capital | 310.73M - | 247.47M 20.36% | 227.24M 8.18% | 363.12M 59.80% | 339.61M 6.47% | 311.14M 8.38% | 361.38M 16.15% | 240.91M 33.34% | 347.45M 44.22% | 553.58M 59.33% |
All numbers in USD (except ratios and percentages)